アクトネル(リセドロン酸)の世界市場2020-2026:5 mg、35 mg、75 mg、150 mg

QYResearchが発行した調査報告書(QYR20AP00015)
◆英語タイトル:Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00015
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、アクトネル(リセドロン酸)の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、アクトネル(リセドロン酸)のグローバル市場動向、メーカー別競争状況、種類別市場規模(5 mg、35 mg、75 mg、150 mg)、用途別市場規模(骨粗鬆症、骨のパジェット病、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・アクトネル(リセドロン酸)の種類別市場2015-2026:5 mg、35 mg、75 mg、150 mg
・アクトネル(リセドロン酸)の用途別市場2015-2026:骨粗鬆症、骨のパジェット病、その他
・アクトネル(リセドロン酸)の北米市場分析
・アクトネル(リセドロン酸)のアジア市場分析
・アクトネル(リセドロン酸)の中南米市場分析
・アクトネル(リセドロン酸)の中東・アフリカ市場分析
・関連企業情報:Allergan plc (AbbVie Inc.)、Takeda、Apotex、Warner Chilcott、Teva Pharmaceutical Industries、Mylan、Macleods Pharmaceuticals Ltd、Aurobindo Pharma、Sun Pharmaceutical Industries Ltd.
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Actonel (Risedronic Acid) ( CAS 105462-24-6).The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market. Readers of the report can become informed about current and future trends of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Actonel (Risedronic Acid) ( CAS 105462-24-6) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Actonel (Risedronic Acid) ( CAS 105462-24-6) market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Actonel (Risedronic Acid) ( CAS 105462-24-6) market is segmented into
5 mg
35 mg
75 mg
150 mg

Market Segment by Application, the Actonel (Risedronic Acid) ( CAS 105462-24-6) market is segmented into
Osteoporosis
Paget’s Disease of Bone
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Allergan plc (AbbVie Inc.)
Takeda
Apotex
Warner Chilcott
Teva Pharmaceutical Industries
Mylan
Macleods Pharmaceuticals Ltd
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.

The study objectives are:
To analyze and research the global Actonel (Risedronic Acid) ( CAS 105462-24-6) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Actonel (Risedronic Acid) ( CAS 105462-24-6) manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Actonel (Risedronic Acid) ( CAS 105462-24-6) are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Actonel (Risedronic Acid) ( CAS 105462-24-6) Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 5 mg
1.3.3 35 mg
1.3.4 75 mg
1.3.5 150 mg
1.4 Market Segment by Application
1.4.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Osteoporosis
1.4.3 Paget’s Disease of Bone
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue (2015-2026)
2.1.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue (2015-2026)
2.1.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales (2015-2026)
2.2 Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Regions (2015-2020)
2.2.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Regions (2015-2020)
2.3 Global Top Actonel (Risedronic Acid) ( CAS 105462-24-6) Regions (Countries) Ranking by Market Size
2.4 Actonel (Risedronic Acid) ( CAS 105462-24-6) Industry Trends
2.4.1 Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Top Trends
2.4.2 Market Drivers
2.4.3 Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Actonel (Risedronic Acid) ( CAS 105462-24-6) Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Actonel (Risedronic Acid) ( CAS 105462-24-6) Manufacturers by Sales (2015-2020)
3.1.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Manufacturers (2015-2020)
3.1.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales in 2019
3.2 Global Top Manufacturers Actonel (Risedronic Acid) ( CAS 105462-24-6) by Revenue
3.2.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Manufacturers (2015-2020)
3.2.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actonel (Risedronic Acid) ( CAS 105462-24-6) as of 2019)
3.4 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Actonel (Risedronic Acid) ( CAS 105462-24-6) Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Actonel (Risedronic Acid) ( CAS 105462-24-6) Market
3.7 Key Manufacturers Actonel (Risedronic Acid) ( CAS 105462-24-6) Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Historic Market Review by Type (2015-2020)
4.1.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Market Share by Type (2015-2020)
4.1.3 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Market Share by Type (2015-2020)
4.1.4 Actonel (Risedronic Acid) ( CAS 105462-24-6) Price by Type (2015-2020)
4.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast by Type (2021-2026)
4.2.3 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast by Type (2021-2026)
4.2.4 Actonel (Risedronic Acid) ( CAS 105462-24-6) Price Forecast by Type (2021-2026)

5 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Size by Application
5.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Historic Market Review by Application (2015-2020)
5.1.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Market Share by Application (2015-2020)
5.1.3 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Market Share by Application (2015-2020)
5.1.4 Actonel (Risedronic Acid) ( CAS 105462-24-6) Price by Application (2015-2020)
5.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast by Application (2021-2026)
5.2.3 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast by Application (2021-2026)
5.2.4 Actonel (Risedronic Acid) ( CAS 105462-24-6) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Company
6.2 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Type
6.3 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Application
6.4 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Countries
6.4.1 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Countries
6.4.2 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Company
7.2 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Type
7.3 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Application
7.4 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Countries
7.4.1 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Countries
7.4.2 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Company
8.2 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Type
8.3 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Application
8.4 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Regions
8.4.1 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Regions
8.4.2 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Company
9.2 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Type
9.3 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Application
9.4 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Countries
9.4.1 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Countries
9.4.2 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Type
10.2 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Application
10.3 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Breakdown Data by Countries
10.3.1 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales by Countries
10.3.2 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Allergan plc (AbbVie Inc.)
11.1.1 Allergan plc (AbbVie Inc.) Corporation Information
11.1.2 Allergan plc (AbbVie Inc.) Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Allergan plc (AbbVie Inc.) Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.1.5 Allergan plc (AbbVie Inc.) SWOT Analysis
11.1.6 Allergan plc (AbbVie Inc.) Recent Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Takeda Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Takeda Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.2.5 Takeda SWOT Analysis
11.2.6 Takeda Recent Developments
11.3 Apotex
11.3.1 Apotex Corporation Information
11.3.2 Apotex Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Apotex Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Apotex Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.3.5 Apotex SWOT Analysis
11.3.6 Apotex Recent Developments
11.4 Warner Chilcott
11.4.1 Warner Chilcott Corporation Information
11.4.2 Warner Chilcott Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Warner Chilcott Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Warner Chilcott Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.4.5 Warner Chilcott SWOT Analysis
11.4.6 Warner Chilcott Recent Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Corporation Information
11.5.2 Teva Pharmaceutical Industries Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Teva Pharmaceutical Industries Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical Industries Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.5.5 Teva Pharmaceutical Industries SWOT Analysis
11.5.6 Teva Pharmaceutical Industries Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Mylan Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Mylan Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.6.5 Mylan SWOT Analysis
11.6.6 Mylan Recent Developments
11.7 Macleods Pharmaceuticals Ltd
11.7.1 Macleods Pharmaceuticals Ltd Corporation Information
11.7.2 Macleods Pharmaceuticals Ltd Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Macleods Pharmaceuticals Ltd Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.7.5 Macleods Pharmaceuticals Ltd SWOT Analysis
11.7.6 Macleods Pharmaceuticals Ltd Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Aurobindo Pharma Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Aurobindo Pharma Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.8.5 Aurobindo Pharma SWOT Analysis
11.8.6 Aurobindo Pharma Recent Developments
11.9 Sun Pharmaceutical Industries Ltd.
11.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information
11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Sun Pharmaceutical Industries Ltd. Actonel (Risedronic Acid) ( CAS 105462-24-6) Products and Services
11.9.5 Sun Pharmaceutical Industries Ltd. SWOT Analysis
11.9.6 Sun Pharmaceutical Industries Ltd. Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Channels
12.2.2 Actonel (Risedronic Acid) ( CAS 105462-24-6) Distributors
12.3 Actonel (Risedronic Acid) ( CAS 105462-24-6) Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.1.1 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast by Regions (2021-2026)
13.1.2 Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.2.2 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast (2021-2026)
13.2.3 North America Actonel (Risedronic Acid) ( CAS 105462-24-6) Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.3.2 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast (2021-2026)
13.3.3 Europe Actonel (Risedronic Acid) ( CAS 105462-24-6) Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.4.2 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Actonel (Risedronic Acid) ( CAS 105462-24-6) Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.5.2 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast (2021-2026)
13.5.3 Latin America Actonel (Risedronic Acid) ( CAS 105462-24-6) Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Actonel (Risedronic Acid) ( CAS 105462-24-6) Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Allergan plc (AbbVie Inc.)、Takeda、Apotex、Warner Chilcott、Teva Pharmaceutical Industries、Mylan、Macleods Pharmaceuticals Ltd、Aurobindo Pharma、Sun Pharmaceutical Industries Ltd.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アクトネル(リセドロン酸)の世界市場2020-2026:5 mg、35 mg、75 mg、150 mg(Global Actonel (Risedronic Acid) ( CAS 105462-24-6) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。